IVUPDATE from IVTEAM

IVTEAM is a global resource for vascular access and infusion therapy, dedicated to supporting clinical teams worldwide. Our daily updates help healthcare professionals stay current with the latest evidence in vascular access and infusion therapy.

IV catheter management survey

“Despite a general alignment with evidence-based standards in certain areas, variation persists in practices such as disinfection methods, flushing techniques, and locking strategies” Hernández et al (2026).

Read More »

Optimising long-term vascular access

“This article provides an overview of central venous access devices, with a particular focus on the benefits of implantable ports for long-term care and the role of the Safetouch Huber Infusion Set in facilitating access to implantable ports” Mozas et al (2026).

Read More »

Comparing catheters to fistulas in older patients starting hemodialysis

“Findings from this trial suggest that conducting a definitive randomized trial of fistulas versus catheters is not feasible in the current climate. There was no signal of harm associated with randomization to the catheter strategy and most outcomes favored the catheter group. Patients exhibited strong preferences regarding choice of vascular access” Quinn et al (2026).

Read More »

Electronic health record impact on CLABSI rates – Full Text

“Higher EHR-derived care-exposure burden was associated with higher odds of adjudicated CLABSI or CLABSI-like bloodstream infection. The score should be interpreted as a pragmatic patient-level marker of cumulative care complexity and infection-prevention prioritisation, rather than as a causal measure of care quality or nursing performance” Li et al (2026).

Read More »

Role of antiseptic barrier caps in CLABSI reduction

“There was a 68% reduction in CLABSI events. By the end of 2024, the unit achieved a CLABSI standardized infection ratio of 0.414, representing a substantial improvement compared to the 2023 ratio of 1.45. The cost avoidance from ABC implementation was about $320,787. CLABSI reduction was sustained in 2025, and ABCs were implemented on the hematology-oncology unit” Rowland Rutledge et al (2026).

Read More »